ReviewFrontiers in immunology2026
Targeting macrophage polarization: mechanisms and potential of mesenchymal stromal/stem cells therapy in acne treatment- a narrative review.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acne vulgaris(AV) is a clinically common skin disease. Globally, about one in ten individuals is affected by it. Current research on acne primarily focuses on the following four areas: first, the inflammatory response; second, sebum metabolism disorders; third, the colonization of Cutibacterium acnes (C. acnes); and fourth, abnormal keratinization of the pilosebaceous duct. Although the exact pathogenesis of this condition has not yet been fully elucidated, the dual polarization of macrophages play a crucial role in the onset, progression and outcome of acne. As key effector cells in the human immune system, macrophages can exhibit different phenotypes in the microenvironments of various diseases: the classical activated phenotype (M1), the alternative activated phenotype (M2), and a subset characterized by the expression of trigger receptor 2 (TREM2) in myeloid cells. Currently endorsed international acne therapy, encompassing topical agents, systemic drugs, and physical therapies, demonstrates efficacy but frequently elicits a range of adverse effects. Therefore, there is a pressing need for a new, ideal treatment approach. Extensive research on stem cells and their derivatives in recent years has shown that mesenchymal stromal/stem cells (MSCs) possess significant immunomodulatory and anti-inflammatory capabilities, particularly in terms of influencing macrophage polarization. They promote the transition of macrophages to the anti-inflammatory M2 phenotype, which may play a role in the recovery process of acne. The unique advantage of MSCs therapy is that it is not simply antibacterial or anti-inflammatory as traditional therapies; rather, it may alleviate inflammation and promote skin tissue repair by promoting polarization of M2 macrophages. At the same time, it is expected to avoid the common adverse reactions in current acne treatment methods. This paper aims to provide a narrative review on the function of macrophages in skin tissue, the core role of inflammatory responses in acne pathogenesis, the multifaceted functions of macrophages in acne, the mechanisms through which MSCs regulate macrophage polarization, the current guideline-recommended standard treatment protocols for acne, and the feasibility of MSCs and their derivative transplants as a therapeutic strategy for alleviating acne inflammation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.